Skip to content

Effects of electrical stimulation of the quadriceps muscle strength and walking capacities in patients with chronic kidney disease on hemodialysis

Peripheral effects of electrical stimulation on peripheral muscle strength and exercise capacity in patients with chronic kidney disease on hemodialysis

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
REBEC
Registry ID
RBR-6wvb5c
Enrollment
Unknown
Registered
2016-03-01
Start date
2015-08-11
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the genitourinary system. Renal Insufficiency, Chronic. Renal Dialysis. End-stage renal disease.

Interventions

Device
E05.723.402
Two groups (Group training and Sham group) conducted training with peripheral electrical stimulation isometric form in lateral and medial bilaterally vast, held three times a week, lasting an hour, th

Sponsors

Universidade do Estado de Santa Catarina
Lead Sponsor
Universidade do Estado de Santa Catarina
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients with CKD diagnostic who are on dialysis regularly for at least 6 months, stable and under medical supervision; patients without: uncontrolled hypertension, recent ischemic heart disease (3 months or less), unstable angina and severe cardiac arrhythmias; patients without diseases that limit the electrical stimulation protocol (respiratory, orthopedic and / or neurological); patients who do not do any form of physical training or who have been held for more than six months.

Exclusion criteria

Exclusion criteria: Inability to perform any of the study assessments (lack of understanding or collaboration); recent decompensation of the clinical picture with or without hospitalization; presence of chronic obstructive pulmonary disease (COPD or emphysema), musculoskeletal diseases that impede the realization of assessments and training protocol, uncontrolled hypertension, recent ischemic heart disease (3 months or less), unstable angina and severe cardiac arrhythmias; abnormal sensitivity in the lower limbs.

Design outcomes

Primary

MeasureTime frame
Peripheral muscle strength: increased quadriceps strength evaluated by the Isokinetic Biodex System 4 Pro in isometric mode. The highest peak extensor torque is recorded compared before and after training. Six-minute walk test: will be used to evaluate submaximal exercise capacity and will be held in accordance with the recommendations of the American Thoracic Society (Holland et al, 2014.). The greater distance between the two tests will be used for the analysis, this being compared to pre and after training. The reference values are those described by Britto et al., 2013 and an increase of 25 meters after the training will be considered a clinically important improvement.

Secondary

MeasureTime frame
Pulmonary function test: performed with the portable digital spirometer the following parameters are obtained: forced vital capacity (FVC), forced expiratory volume in one second (FEV1) and the FEV1 / FVC ratio expressed in absolute terms and in percentage of predicted values normality according to the determined by Pereira et al. (2007). The values ??are compared before and after intervention. venocapillary pulmonary congestion: assessed by ultrasound, the severity of pulmonary congestion will be categorized into three classes according to the number of signs of cometary tails (light: 14 comets; moderate: 14-30 comets; severe: 30 comets). Values ??are compared pre- to post-intervention. Diaphragm mobility: assessed by ultrasound at craniocaudal displacement of the left branch of the vein cava during inspiration and maximum expiration. The values ??are compared to pre post intervention. Balance reviewed evaluated by 3 Smart Equitest System tests (NeuroCom), which will present a score. The values ??are compared to pre post intervention to see if there were improvements. Quality of life will be measured using the questionnaire Kidney Disease and Quality-of-Life Short Form (SF KDQOL-), the degree of commitment of each domain is measured by values ??ranging from zero (greater degree of commitment) 100 (no impairment). Thus, the higher the score, the better the quality of life. The questionnaire will be pre to post intervention to see if there were improvements. Anxiety and Depression: It used the Hospital Anxiety and Depression Scale - HADS (Hospital Anxiety and Depression Scale). The overall scores for each subscales (anxiety or depression) ranges from 0 to 21, where 0 corresponds to the lowest level of depression or anxiety and 21 at most. At the end, add up the scores of anxiety and depression. The scale is reapplied to the end of the training to compare the scores. physical activity in daily life, performed with a triaxial accelerometer that is able to d

Countries

Brazil

Contacts

Public ContactElaine Paulin

Universidade do Estado de Santa Catarina

lainepaulin@gmail.com+55(48)33218602

Outcome results

None listed

Source: REBEC (via WHO ICTRP)